Archives: Teams

Rob Maguire is a medicinal chemist focused on the design and development of PDCs for the treatment of cancer.  Following completion of his PhD at the University of Manchester and post-doctoral research in Germany and Canada, Rob started his career with Pfizer medicinal chemistry in Sandwich, UK.  Rob joined Cybrexa in October 2019 and led the chemistry team for CBX-12 through pre-clinical studies to late Phase 1.  His work is now focused on developing new expressions of the Alphalex™ platform to broaden the reach of this powerful PDC technology in the treatment of cancer.

Sophia Gayle is a biologist specializing in early drug development and biomarker discovery. Sophia trained in Tian Xu’s laboratory at Yale University in the development and application of novel forward-genetics technologies in human embryonic stem cells. After her PhD, she worked in the field of drug repurposing for oncology and rare disease indications.  Sophia joined Cybrexa in January of 2019 and leads both in vitro and in vivo biology teams.